Dr. Filomela Marshall, dean of the W. Cary Edwards School of Nursing
Thomas Edison State University has received a $30,000 grant from Bristol-Myers Squibb in support of the institution’s Accelerated 2nd Degree BSN Program (Accelerated BSN).
This grant provides financial support to help cover tuition costs for up to 15 nursing students enrolled in the 2017-2018 Accelerated BSN cohort. Students in this program already possess another baccalaureate degree and thus face unique financial struggles. Their eligibility for Pell grants and other financial aid is limited, as 95 percent of them already carry loans from their previous baccalaureate degree programs. Additionally, students in the Accelerated BSN are strongly discouraged from working while enrolled due to the program’s rigorous nature.
“I am grateful for the continued support of Bristol-Myers Squibb to the W. Cary Edwards School of Nursing,” said Dr. Phyllis Marshall, dean of the W. Cary Edwards School of Nursing. “This commitment to nursing scholarships enables our students to reach their goal of becoming nurses who provide high quality care to the communities that they serve.”
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company, focused in discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. As global citizens, BMS works sustainably, responsibly and seeks to give back to the community, in part through the New Jersey Community Giving Program. The NJ Giving program is focused on improving STEM education in underserved communities and building a diverse STEM pipeline of future professionals.
“We are proud to support the nurses of tomorrow through our grant to the W. Cary Edwards School of Nursing,” said Johanna Mercier, head of the U.S. Commercial organization, Bristol-Myers Squibb. “Building a strong pipeline of STEM professionals is important to our mission to help patients overcome serious disease – with nurses at the center of the care continuum.”
Toni M. Terry, BA